BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
1245 results:

  • 1. Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia.
    Yang T; Gou H; Lin T; Yang Y; Jin X; Dong T; Zhang Y; Chen X
    Int J Pharm; 2024 Apr; 654():123971. PubMed ID: 38452832
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neutrophilic Dermatosis of the Hands: A Case Report.
    Yaghoobi R; Bagherani N; R Smoller B; Pazyar N
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):148-50. PubMed ID: 38439725
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.
    Booth MR; Booth L; Roberts JL; West C; Dent P
    Oncotarget; 2024 Feb; 15():124-133. PubMed ID: 38329728
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
    Goto H; Ito S; Kizaki M; Yamaguchi M; Fukuhara N; Kato K; Saito T; Terui Y; Okubo S; Soshin T; Zeng J; Honda H; Badawi M; Ross JA; Izutsu K
    Int J Clin Oncol; 2024 Feb; 29(2):232-240. PubMed ID: 38157190
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical Characteristics And Treatment Outcome Of Paediatric Non-Hodgkin's lymphoma At A Tertiary Care Hospital In Pakistan.
    Naqvi J; Sajid MI; Khan S; Nisa Kamran ZU; Fadoo Z
    J Pak Med Assoc; 2023 Nov; 73(11):2161-2164. PubMed ID: 38013521
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer.
    Tanabe S; Boonstra E; Hong T; Quader S; Ono R; Cabral H; Aoyagi K; Yokozaki H; Perkins EJ; Sasaki H
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003016
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
    V Stackelberg A; Jäschke K; Jousseaume E; Templin C; Jeratsch U; Kosmides D; Steffen I; Gökbuget N; Peters C
    Leukemia; 2023 Dec; 37(12):2346-2355. PubMed ID: 37880478
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Study of anticancer effects of platinum levetiracetam and levetiracetam via cancer biomarkers genes expression on HepG2 cell line.
    Sabokrouh A; Sadeghi Motlagh B; Atabi F
    Mol Biol Rep; 2023 Nov; 50(11):9431-9439. PubMed ID: 37831345
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Interim results of a multicenter cohort study for Chinese Children Leukemia Group-acute lymphoblastic leukemia 2018 regimen].
    Chinese Children Leukemia Group
    Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
    [No Abstract]    [Full Text] [Related]  

  • 10. Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL.
    Tam C; Pinilla-Ibarz J; Castillo CG; Fenili AC; Huntley K; Karakus V; Mattar M; Miroli MA; Moura C; Pavlovsky M; Piotrowski F; Šimkovič M; Stilgenbauer S
    Blood Adv; 2023 Nov; 7(22):6819-6828. PubMed ID: 37722356
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
    Paskiewicz A; Niu J; Chang C
    Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the fas/fasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.
    Ge F; Wang Y; Sharma A; Yang Y; Liu H; Essler M; Jaehde U; Schmidt-Wolf IGH
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569852
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Apoptosis-mediated inhibition of human T-cell acute lymphoblastic leukemia upon treatment with
    Duarte A; Montagna DR; Pastorini M; Alemán M
    Front Immunol; 2023; 14():1176432. PubMed ID: 37377961
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.
    Jorge J; Neves J; Alves R; Geraldes C; Gonçalves AC; Sarmento-Ribeiro AB
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298119
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
    Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
    Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B-ALL in CR1 with no detectable minimal residual disease.
    Lv M; Liu L; He Y; Yang D; Ma Q; Pang A; Zhai W; Wei J; Huang Y; Chen X; Zhang G; Feng S; Han M; Jiang E; Zhang R
    Br J Haematol; 2023 Jul; 202(2):369-378. PubMed ID: 37157187
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
    Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
    World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
    Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
    Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinical characteristics and prognosis of primary and secondary diffuse large B-cell lymphoma of the pancreas].
    Huo YJ; Zhang MC; Shi Q; Qin W; Shi ZY; Wang L; Cheng S; Xu PP; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):55-61. PubMed ID: 36987724
    [No Abstract]    [Full Text] [Related]  

  • 20. Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal lymphoma With Methotrexate.
    Gu J; Jiang T; Liu S; Chen X; Wang Z; Zhang P; Wang L; Jiang R; Huang X; Xu G; Chang Q
    Am J Ophthalmol; 2023 Jul; 251():189-196. PubMed ID: 36963600
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 63.